Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice

Drug Metabolism and Disposition

Volumn 40, Issue 6, 2012, Pages 1226-1237

  Cui, JuliaYue ^a   Renaud, Helen J ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A; CYTOCHROME P450 2A5; CYTOCHROME P450 2B; CYTOCHROME P450 2B9; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 3A11; CYTOCHROME P450 4A; CYTOCHROME P450 4B1; ISOENZYME; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BIRTH; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME 9; CONTROLLED STUDY; CYTOCHROME P450 1A1 GENE; CYTOCHROME P450 1A2 GENE; CYTOCHROME P450 1B1 GENE; CYTOCHROME P450 2A22 GENE; CYTOCHROME P450 2A4 GENE; CYTOCHROME P450 2A5 GENE; CYTOCHROME P450 2B10 GENE; CYTOCHROME P450 2B13 GENE; CYTOCHROME P450 2B19 GENE; CYTOCHROME P450 2B23 GENE; CYTOCHROME P450 2B9 GENE; CYTOCHROME P450 2C29 GENE; CYTOCHROME P450 2C37 GENE; CYTOCHROME P450 2C38 GENE; CYTOCHROME P450 2C39 GENE; CYTOCHROME P450 2C40 GENE; CYTOCHROME P450 2C44 GENE; CYTOCHROME P450 2C50 GENE; CYTOCHROME P450 2C54 GENE; CYTOCHROME P450 2C55 GENE; CYTOCHROME P450 2C66 GENE; CYTOCHROME P450 2C67 GENE; CYTOCHROME P450 2C68 GENE; CYTOCHROME P450 2C69 GENE; CYTOCHROME P450 2C70 GENE; CYTOCHROME P450 2D10 GENE; CYTOCHROME P450 2D11 GENE; CYTOCHROME P450 2D12 GENE; CYTOCHROME P450 2D22 GENE; CYTOCHROME P450 2D26 GENE; CYTOCHROME P450 2D34 GENE; CYTOCHROME P450 2D40 GENE; CYTOCHROME P450 2D9 GENE; CYTOCHROME P450 2E1 GENE; CYTOCHROME P450 2F GENE; CYTOCHROME P450 2F2 GENE; CYTOCHROME P450 2G GENE; CYTOCHROME P450 2G1 GENE; CYTOCHROME P450 2J11 GENE; CYTOCHROME P450 2J12 GENE; CYTOCHROME P450 2J13 GENE; CYTOCHROME P450 2J5 GENE; CYTOCHROME P450 2J6 GENE; CYTOCHROME P450 2J7 GENE; CYTOCHROME P450 2J8 GENE; CYTOCHROME P450 2J9 GENE; CYTOCHROME P450 2S GENE; CYTOCHROME P450 2T4 GENE; CYTOCHROME P450 2U1 GENE; CYTOCHROME P450 2W1 GENE; CYTOCHROME P450 3A11 GENE; CYTOCHROME P450 3A13 GENE; CYTOCHROME P450 3A16 GENE; CYTOCHROME P450 3A25 GENE; CYTOCHROME P450 3A41A GENE; CYTOCHROME P450 3A41B GENE; CYTOCHROME P450 3A44 GENE; CYTOCHROME P450 3A57 GENE; CYTOCHROME P450 3A59 GENE; CYTOCHROME P450 4A10 GENE; CYTOCHROME P450 4A12A GENE; CYTOCHROME P450 4A12B GENE; CYTOCHROME P450 4A14 GENE; CYTOCHROME P450 4A16 GENE; CYTOCHROME P450 4A17 GENE; CYTOCHROME P450 4A18 GENE; CYTOCHROME P450 4A29 GENE; CYTOCHROME P450 4A30B GENE; CYTOCHROME P450 4A31 GENE; CYTOCHROME P450 4A32 GENE; CYTOCHROME P450 4B1 GENE; CYTOCHROME P450 4F13 GENE; CYTOCHROME P450 4F14 GENE; CYTOCHROME P450 4F15 GENE; CYTOCHROME P450 4F16 GENE; CYTOCHROME P450 4F17 GENE; CYTOCHROME P450 4F18 GENE; CYTOCHROME P450 4F39 GENE; CYTOCHROME P450 4F40 GENE; CYTOCHROME P450 4V3 GENE; CYTOCHROME P450 4X1 GENE; CYTOCHROME P450 GENE; DNA DETERMINATION; FEMALE; GENE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCATION; LIVER DEVELOPMENT; MALE; MOUSE; NONHUMAN; ONTOGENY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; UPREGULATION;

AGE FACTORS; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; ISOENZYMES; LIVER; MALE; MICE; MICE, INBRED C57BL;

MUS;

EID: 84862072168     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.042697     Document Type: Article

References (45)

1. Aleksunes LM, Cui Y, and Klaassen CD (2008) Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab Dispos 36:1960-1970.
2. Alnouti Y and Klaassen CD (2006) Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol Sci 93:242-255. (Pubitemid 44400443)
3. Alnouti Y and Klaassen CD (2008) Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol Sci 101:51-64. (Pubitemid 350239011)
4. Alnouti Y, Petrick JS, and Klaassen CD (2006) Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 34:477-482. (Pubitemid 43290907)
5. Balasubramaniyan N, Shahid M, Suchy FJ, and Ananthanarayanan M (2005) Multiple mechanisms of ontogenic regulation of nuclear receptors during rat liver development. Am J Physiol Gastrointest Liver Physiol 288:G251-G260. (Pubitemid 40129576)
6. Blake MJ, Castro L, Leeder JS, and Kearns GL (2005) Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 10:123-138. (Pubitemid 40215540)
7. Caldwell J (2004) Pharmacogenetics and individual variation in the range of amino acid adequacy: the biological aspects. J Nutr 134:1600S-1604S.
8. Cheng X and Klaassen CD (2009) Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. Drug Metab Dispos 37:2178-2185.
9. Cheng X, Maher J, Chen C, and Klaassen CD (2005) Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps). Drug Metab Dispos 33:1062-1073. (Pubitemid 41002790)
10. Choudhary D, Jansson I, Schenkman JB, Sarfarazi M, and Stoilov I (2003) Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414:91-100. (Pubitemid 36555449)
11. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, and Schenkman JB (2005) Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch Biochem Biophys 436:50-61. (Pubitemid 40332424)
12. Cui JY, Choudhuri S, Knight TR, and Klaassen CD (2010) Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver. Toxicol Sci 116:32-43.
13. Cui YJ, Cheng X, Weaver YM, and Klaassen CD (2009) Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice. Drug Metab Dispos 37:203-210.
14. de Wildt SN, Kearns GL, Leeder JS, and van den Anker JN (1999) Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 37:485-505. (Pubitemid 30032252)
15. Estabrook RW (2003) A passion for P450s (remembrances of the early history of research on cytochrome P450). Drug Metab Dispos 31:1461-1473.
16. Fouts JR and Adamson RH (1959) Drug metabolism in the newborn rabbit. Science 129:897-898.
17. Gaedigk A, Baker DW, Totah RA, Gaedigk R, Pearce RE, Vyhlidal CA, Zeldin DC, and Leeder JS (2006) Variability of CYP2J2 expression in human fetal tissues. J Pharmacol Exp Ther 319:523-532.
18. Hart SN, Cui Y, Klaassen CD, and Zhong XB (2009) Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos 37:116-121.
19. Hernandez JP, Mota LC, Huang W, Moore DD, and Baldwin WS (2009) Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR). Toxicology 256:53-64.
20. Hines RN (2007) Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 21:169-175.
21. Kang HS, Angers M, Beak JY, Wu X, Gimble JM, Wada T, Xie W, Collins JB, Grissom SF, and Jetten AM (2007) Gene expression profiling reveals a regulatory role for ROR α and ROR γ in phase I and phase II metabolism. Physiol Genomics 31:281-294. (Pubitemid 350014406)
22. Kawamoto T, Kakizaki S, Yoshinari K, and Negishi M (2000) Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol Endocrinol 14:1897-1905.
23. Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, and Hines RN (2004) Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 308:965-974. (Pubitemid 38263972)
24. Lacroix D, Sonnier M, Moncion A, Cheron G, and Cresteil T (1997) Expression of CYP3A in the human liver - evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625-634. (Pubitemid 27308642)
25. Leeder JS, Gaedigk R, Marcucci KA, Gaedigk A, Vyhlidal CA, Schindel BP, and Pearce RE (2005) Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther 314:626-635. (Pubitemid 41043843)
26. Li X, Schuler MA, and Berenbaum MR (2007) Molecular mechanisms of metabolic resistance to synthetic and natural xenobiotics. Annu Rev Entomol 52:231-253. (Pubitemid 46133570)
27. Li XY, Zhang C, Wang H, Ji YL, Wang SF, Zhao L, Chen X, and Xu DX (2008) Tumor necrosis factor α partially contributes to lipopolysaccharide- induced downregulation of CYP3A in fetal liver: its repression by a low dose LPS pretreatment. Toxicol Lett 179:71-77.
28. Li Y, Cui Y, Hart SN, Klaassen CD, and Zhong XB (2009) Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol Pharmacol 75:1171-1179.
29. Löfgren S, Baldwin RM, Carlerös M, Terelius Y, Fransson-Steen R, Mwinyi J, Waxman DJ, and Ingelman-Sundberg M (2009) Regulation of human CYP2C18 and CYP2C19 in transgenic mice: influence of castration, testosterone, and growth hormone. Drug Metab Dispos 37:1505-1512.
30. Maher JM, Slitt AL, Cherrington NJ, Cheng X, and Klaassen CD (2005) Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab Dispos 33:947-955. (Pubitemid 41002776)
31. Nebert DW and Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155-1162. (Pubitemid 35246494)
32. Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, and Nebert DW (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1-18. (Pubitemid 38183957)
33. Petrick JS and Klaassen CD (2007) Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab Dispos 35:1806-1815. (Pubitemid 47481572)
34. Renaud HJ, Cui JY, Khan M, and Klaassen CD (2011) Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice. Toxicol Sci 124:261-277.
35. Rich KJ and Boobis AR (1997) Expression and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech 39:424-435. (Pubitemid 27523011)
36. Rowell M and Zlotkin S (1997) The ethical boundaries of drug research in pediatrics. Pediatr Clin North Am 44:27-40. (Pubitemid 27102454)
37. Schuetz JD, Beach DL, and Guzelian PS (1994) Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11-20.
38. Sonnier M and Cresteil T (1998) Delayed ontogenesis of CYP1A2 in the human liver. Eur J Biochem 251:893-898. (Pubitemid 28108986)
39. Stevens JC, Marsh SA, Zaya MJ, Regina KJ, Divakaran K, Le M, and Hines RN (2008) Developmental changes in human liver CYP2D6 expression. Drug Metab Dispos 36:1587-1593.
40. Treluyer JM, Gueret G, Cheron G, Sonnier M, and Cresteil T (1997) Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility. Pharmacogenetics 7:441-452. (Pubitemid 27517572)
41. Waxman DJ and Holloway MG (2009) Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 76:215-228.
42. Wei P, Zhang J, Egan-Hafley M, Liang S, and Moore DD (2000) The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407:920-923.
43. Werner T (2010) Next generation sequencing in functional genomics. Brief Bioinform 11:499-511.
44. Williams A and Flavell RA (2008) The role of CTCF in regulating nuclear organization. J Exp Med 205:747-750. (Pubitemid 351549873)
45. Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, and Vandenbranden M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207-213. (Pubitemid 20255306)